Journal of Biomedical Materials Research Part A, Год журнала: 2024, Номер 113(1)
Опубликована: Дек. 25, 2024
ABSTRACT Precise blood glucose control continues to be a critical challenge in the treatment and management of type 1 diabetes order mitigate both acute chronic complications. This study investigates development supramolecular peptide amphiphile (PA) material functionalized with phenylboronic acid (PBA) for glucose‐responsive glucagon delivery. The PA‐PBA system self‐assembles into nanofibrillar hydrogels presence physiological levels, resulting stable capable releasing under hypoglycemic conditions. Glucose responsiveness is driven by reversible binding between PBA glucose, which modulates electrostatic interactions necessary hydrogel formation dissolution. Through comprehensive vitro characterization, including circular dichroism, zeta potential measurements, rheological assessments, found exhibit glucose‐dependent assembly, enabling controlled release that inversely related concentration. Glucagon accelerated low conditions, simulating state, reduced rate seen at higher levels. Evaluation platform vivo using diabetic mouse model demonstrates efficacy protecting against insulin‐induced hypoglycemia restoring levels following an insulin overdose. ability tailor response fluctuating concentrations underscores this improving glycemic control. These findings suggest glucose‐stabilized hold significant promise responsive drug delivery applications, offering approach manage other metabolic disorders.
Язык: Английский